FDA OKs SMA Gene Therapy Itvisma – Medscape

1. FDA OKs SMA Gene Therapy Itvisma  Medscape
2. Muscular Dystrophy Association Calls FDA Approval of Novartis’ Itvisma (onasemnogene abeparvovec-brve) a Major Step Forward for the Spinal Muscular Atrophy Community  Muscular Dystrophy Association
3. ‘Negative Effects’ of TikTok & Instagram Reels Explained by Study  Yahoo
4. Novartis wins approval to use SMA gene therapy in older patients  BioPharma Dive
5. FDA Approves New Intrathecal Administration Route for Spinal Muscular Atrophy Gene Therapy  NeurologyLive

Continue Reading